Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives

March 21, 2018

Lycera patents new Rho-associated protein kinase 1/2 inhibitors

March 19, 2018

New polynucleotides encoding semaphorin-6 synthesized at Kanazawa University

March 8, 2018

Novel NF-kappaB inhibitors synthesized at University College Dublin

March 8, 2018

CYP11A1 expression identifies anaphylaxis risk in children with peanut allergy

March 5, 2018

Bristol-Myers Squibb presents phase Ib data for anti-PD-L1 BMS-936559 in sepsis

March 1, 2018

Accro Bioscience divulges necrosis inhibitors

Feb. 16, 2018

Galecto Biotech discovers galectin inhibitors

Feb. 1, 2018

Blade Therapeutics identifies new calpain inhibitors

Jan. 29, 2018

BI-2545 shows promise for the unmet medical need in IPF treatment

Jan. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...